Docetaxel Market in Japan - Manufacturing and Consumption, Outlook and Forecast 2020-2026
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
This report contains market size and forecasts of Docetaxel in Japan, including the following market information:
Japan Docetaxel Market Revenue, 2015-2020, 2021-2026, ($ millions)
Japan Docetaxel Market Consumption, 2015-2020, 2021-2026, (K Units)
Japan Docetaxel Production Capacity, 2015-2020, 2021-2026, (K Units)
Top Five Competitors in Japan Docetaxel Market 2019 (%)
The global Docetaxel market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Docetaxel market size in Japan was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Docetaxel manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Docetaxel production and consumption in Japan
Total Market by Segment:
Japan Docetaxel Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Units)
Japan Docetaxel Market Segment Percentages, By Type, 2019 (%)
Japan Docetaxel Market Segment Percentages, By Application, 2019 (%)
The report also provides analysis of leading market participants including:
Total Docetaxel Market Competitors Revenues in Japan, by Players 2015-2020 (Estimated), ($ millions)
Total Docetaxel Market Competitors Revenues Share in Japan, by Players 2019 (%)
Total Japan Docetaxel Market Competitors Sales, by Players 2015-2020 (Estimated), (K Units)
Total Japan Docetaxel Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
This report contains market size and forecasts of Docetaxel in Japan, including the following market information:
Japan Docetaxel Market Revenue, 2015-2020, 2021-2026, ($ millions)
Japan Docetaxel Market Consumption, 2015-2020, 2021-2026, (K Units)
Japan Docetaxel Production Capacity, 2015-2020, 2021-2026, (K Units)
Top Five Competitors in Japan Docetaxel Market 2019 (%)
The global Docetaxel market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Docetaxel market size in Japan was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Docetaxel manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Docetaxel production and consumption in Japan
Total Market by Segment:
Japan Docetaxel Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Units)
Japan Docetaxel Market Segment Percentages, By Type, 2019 (%)
- 20 mg/ml
- 40 mg/ml
- 60 mg/ml
Japan Docetaxel Market Segment Percentages, By Application, 2019 (%)
- Breast Cancer
- Prostate Cancer
- Non-small Cell Lung Cancer
- Other
The report also provides analysis of leading market participants including:
Total Docetaxel Market Competitors Revenues in Japan, by Players 2015-2020 (Estimated), ($ millions)
Total Docetaxel Market Competitors Revenues Share in Japan, by Players 2019 (%)
Total Japan Docetaxel Market Competitors Sales, by Players 2015-2020 (Estimated), (K Units)
Total Japan Docetaxel Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
- Hengrui Medicine
- Sanofi
- Qilu Pharma
- Shenzhen Main Luck Pharma
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Docetaxel Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Japan Docetaxel Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: JAPAN DOCETAXEL OVERALL MARKET SIZE
2.1 Japan Docetaxel Market Size: 2020 VS 2026
2.2 Japan Docetaxel Revenue, Prospects & Forecasts: 2015-2026
2.3 Japan Docetaxel Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Docetaxel Players in Japan (including Foreign and Local Companies)
3.2 Top Japan Docetaxel Companies Ranked by Revenue
3.3 Japan Docetaxel Revenue by Companies (including Foreign and Local Companies)
3.4 Japan Docetaxel Sales by Companies (including Foreign and Local Companies)
3.5 Japan Docetaxel Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Docetaxel Companies in Japan, by Revenue in 2019
3.7 Japan Manufacturers Docetaxel Product Type
3.8 Tier 1, Tier 2 and Tier 3 Docetaxel Players in Japan
3.8.1 List of Japan Tier 1 Docetaxel Companies
3.8.2 List of Japan Tier 2 and Tier 3 Docetaxel Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Japan Docetaxel Market Size Markets, 2020 & 2026
4.1.2 20 mg/ml
4.1.3 40 mg/ml
4.1.4 60 mg/ml
4.2 By Type - Japan Docetaxel Revenue & Forecasts
4.2.1 By Type - Japan Docetaxel Revenue, 2015-2020
4.2.2 By Type - Japan Docetaxel Revenue, 2021-2026
4.2.3 By Type - Japan Docetaxel Revenue Market Share, 2015-2026
4.3 By Type - Japan Docetaxel Sales & Forecasts
4.3.1 By Type - Japan Docetaxel Sales, 2015-2020
4.3.2 By Type - Japan Docetaxel Sales, 2021-2026
4.3.3 By Type - Japan Docetaxel Sales Market Share, 2015-2026
4.4 By Type - Japan Docetaxel Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Japan Docetaxel Market Size, 2020 & 2026
5.1.2 Breast Cancer
5.1.3 Prostate Cancer
5.1.4 Non-small Cell Lung Cancer
5.1.5 Other
5.2 By Application - Japan Docetaxel Revenue & Forecasts
5.2.1 By Application - Japan Docetaxel Revenue, 2015-2020
5.2.2 By Application - Japan Docetaxel Revenue, 2021-2026
5.2.3 By Application - Japan Docetaxel Revenue Market Share, 2015-2026
5.3 By Application - Japan Docetaxel Sales & Forecasts
5.3.1 By Application - Japan Docetaxel Sales, 2015-2020
5.3.2 By Application - Japan Docetaxel Sales, 2021-2026
5.3.3 By Application - Japan Docetaxel Sales Market Share, 2015-2026
5.4 By Application - Japan Docetaxel Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 Hengrui Medicine
6.1.1 Hengrui Medicine Corporate Summary
6.1.2 Hengrui Medicine Business Overview
6.1.3 Hengrui Medicine Docetaxel Major Product Offerings
6.1.4 Hengrui Medicine Sales and Revenue in Japan (2015-2020)
6.1.5 Hengrui Medicine Key News
6.2 Sanofi
6.2.1 Sanofi Corporate Summary
6.2.2 Sanofi Business Overview
6.2.3 Sanofi Docetaxel Major Product Offerings
6.2.4 Sanofi Sales and Revenue in Japan (2015-2020)
6.2.5 Sanofi Key News
6.3 Qilu Pharma
6.3.1 Qilu Pharma Corporate Summary
6.3.2 Qilu Pharma Business Overview
6.3.3 Qilu Pharma Docetaxel Major Product Offerings
6.3.4 Qilu Pharma Sales and Revenue in Japan (2015-2020)
6.3.5 Qilu Pharma Key News
6.4 Shenzhen Main Luck Pharma
6.4.1 Shenzhen Main Luck Pharma Corporate Summary
6.4.2 Shenzhen Main Luck Pharma Business Overview
6.4.3 Shenzhen Main Luck Pharma Docetaxel Major Product Offerings
6.4.4 Shenzhen Main Luck Pharma Sales and Revenue in Japan (2015-2020)
6.4.5 Shenzhen Main Luck Pharma Key News
6.5 Jiangsu Aosaikang Pharma
6.5.1 Jiangsu Aosaikang Pharma Corporate Summary
6.5.2 Jiangsu Aosaikang Pharma Business Overview
6.5.3 Jiangsu Aosaikang Pharma Docetaxel Major Product Offerings
6.5.4 Jiangsu Aosaikang Pharma Sales and Revenue in Japan (2015-2020)
6.5.5 Jiangsu Aosaikang Pharma Key News
7 DOCETAXEL PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Docetaxel Production Capacity and Value in Japan, Situation Analysis and Prediction, 2015-2026
7.1.1 Japan Docetaxel Production Capacity, 2015-2026
7.1.2 Japan Docetaxel Production 2015-2026
7.1.3 Japan Docetaxel Production Value 2015-2026
7.2 Key Local Docetaxel Manufacturers in Japan
7.2.1 Japan Key Local Docetaxel Manufacturers Production Capacity
7.2.2 Japan Key Local Docetaxel Manufacturers Production
7.2.3 Japan Key Local Docetaxel Manufacturers Production Value
7.2.4 The Proportion of Docetaxel Production Sold in Japan and Sold Other Than Japan by Manufacturers
7.3 Docetaxel Export and Import in Japan
7.3.1 Japan Docetaxel Export Market
7.3.2 Japan Docetaxel Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for Japan Docetaxel Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON DOCETAXEL SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Docetaxel Distributors and Sales Agents in Japan
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
1.1 Docetaxel Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Japan Docetaxel Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: JAPAN DOCETAXEL OVERALL MARKET SIZE
2.1 Japan Docetaxel Market Size: 2020 VS 2026
2.2 Japan Docetaxel Revenue, Prospects & Forecasts: 2015-2026
2.3 Japan Docetaxel Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Docetaxel Players in Japan (including Foreign and Local Companies)
3.2 Top Japan Docetaxel Companies Ranked by Revenue
3.3 Japan Docetaxel Revenue by Companies (including Foreign and Local Companies)
3.4 Japan Docetaxel Sales by Companies (including Foreign and Local Companies)
3.5 Japan Docetaxel Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Docetaxel Companies in Japan, by Revenue in 2019
3.7 Japan Manufacturers Docetaxel Product Type
3.8 Tier 1, Tier 2 and Tier 3 Docetaxel Players in Japan
3.8.1 List of Japan Tier 1 Docetaxel Companies
3.8.2 List of Japan Tier 2 and Tier 3 Docetaxel Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Japan Docetaxel Market Size Markets, 2020 & 2026
4.1.2 20 mg/ml
4.1.3 40 mg/ml
4.1.4 60 mg/ml
4.2 By Type - Japan Docetaxel Revenue & Forecasts
4.2.1 By Type - Japan Docetaxel Revenue, 2015-2020
4.2.2 By Type - Japan Docetaxel Revenue, 2021-2026
4.2.3 By Type - Japan Docetaxel Revenue Market Share, 2015-2026
4.3 By Type - Japan Docetaxel Sales & Forecasts
4.3.1 By Type - Japan Docetaxel Sales, 2015-2020
4.3.2 By Type - Japan Docetaxel Sales, 2021-2026
4.3.3 By Type - Japan Docetaxel Sales Market Share, 2015-2026
4.4 By Type - Japan Docetaxel Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Japan Docetaxel Market Size, 2020 & 2026
5.1.2 Breast Cancer
5.1.3 Prostate Cancer
5.1.4 Non-small Cell Lung Cancer
5.1.5 Other
5.2 By Application - Japan Docetaxel Revenue & Forecasts
5.2.1 By Application - Japan Docetaxel Revenue, 2015-2020
5.2.2 By Application - Japan Docetaxel Revenue, 2021-2026
5.2.3 By Application - Japan Docetaxel Revenue Market Share, 2015-2026
5.3 By Application - Japan Docetaxel Sales & Forecasts
5.3.1 By Application - Japan Docetaxel Sales, 2015-2020
5.3.2 By Application - Japan Docetaxel Sales, 2021-2026
5.3.3 By Application - Japan Docetaxel Sales Market Share, 2015-2026
5.4 By Application - Japan Docetaxel Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 Hengrui Medicine
6.1.1 Hengrui Medicine Corporate Summary
6.1.2 Hengrui Medicine Business Overview
6.1.3 Hengrui Medicine Docetaxel Major Product Offerings
6.1.4 Hengrui Medicine Sales and Revenue in Japan (2015-2020)
6.1.5 Hengrui Medicine Key News
6.2 Sanofi
6.2.1 Sanofi Corporate Summary
6.2.2 Sanofi Business Overview
6.2.3 Sanofi Docetaxel Major Product Offerings
6.2.4 Sanofi Sales and Revenue in Japan (2015-2020)
6.2.5 Sanofi Key News
6.3 Qilu Pharma
6.3.1 Qilu Pharma Corporate Summary
6.3.2 Qilu Pharma Business Overview
6.3.3 Qilu Pharma Docetaxel Major Product Offerings
6.3.4 Qilu Pharma Sales and Revenue in Japan (2015-2020)
6.3.5 Qilu Pharma Key News
6.4 Shenzhen Main Luck Pharma
6.4.1 Shenzhen Main Luck Pharma Corporate Summary
6.4.2 Shenzhen Main Luck Pharma Business Overview
6.4.3 Shenzhen Main Luck Pharma Docetaxel Major Product Offerings
6.4.4 Shenzhen Main Luck Pharma Sales and Revenue in Japan (2015-2020)
6.4.5 Shenzhen Main Luck Pharma Key News
6.5 Jiangsu Aosaikang Pharma
6.5.1 Jiangsu Aosaikang Pharma Corporate Summary
6.5.2 Jiangsu Aosaikang Pharma Business Overview
6.5.3 Jiangsu Aosaikang Pharma Docetaxel Major Product Offerings
6.5.4 Jiangsu Aosaikang Pharma Sales and Revenue in Japan (2015-2020)
6.5.5 Jiangsu Aosaikang Pharma Key News
7 DOCETAXEL PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Docetaxel Production Capacity and Value in Japan, Situation Analysis and Prediction, 2015-2026
7.1.1 Japan Docetaxel Production Capacity, 2015-2026
7.1.2 Japan Docetaxel Production 2015-2026
7.1.3 Japan Docetaxel Production Value 2015-2026
7.2 Key Local Docetaxel Manufacturers in Japan
7.2.1 Japan Key Local Docetaxel Manufacturers Production Capacity
7.2.2 Japan Key Local Docetaxel Manufacturers Production
7.2.3 Japan Key Local Docetaxel Manufacturers Production Value
7.2.4 The Proportion of Docetaxel Production Sold in Japan and Sold Other Than Japan by Manufacturers
7.3 Docetaxel Export and Import in Japan
7.3.1 Japan Docetaxel Export Market
7.3.2 Japan Docetaxel Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for Japan Docetaxel Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON DOCETAXEL SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Docetaxel Distributors and Sales Agents in Japan
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Docetaxel in Japan
Table 2. Top Players in Japan, Ranking by Revenue (2019)
Table 3. Japan Docetaxel Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Japan Docetaxel Revenue Share by Companies, 2015-2020
Table 5. Japan Docetaxel Sales by Companies, (K Units), 2015-2020
Table 6. Japan Docetaxel Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Docetaxel Price (2015-2020) (USD/Unit)
Table 8. Japan Manufacturers Docetaxel Product Type
Table 9. List of Japan Tier 1 Docetaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Japan Tier 2 and Tier 3 Docetaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Docetaxel Revenue in Japan (US$, Mn), 2015-2020
Table 12. By Type - Docetaxel Revenue in Japan (US$, Mn), 2021-2026
Table 13. By Type - Docetaxel Sales in Japan (K Units), 2015-2020
Table 14. By Type - Docetaxel Sales in Japan (K Units), 2021-2026
Table 15. By Application - Docetaxel Revenue in Japan, (US$, Mn), 2015-2020
Table 16. By Application - Docetaxel Revenue in Japan, (US$, Mn), 2021-2026
Table 17. By Application - Docetaxel Sales in Japan, (K Units), 2015-2020
Table 18. By Application - Docetaxel Sales in Japan, (K Units), 2021-2026
Table 19. Hengrui Medicine Corporate Summary
Table 20. Hengrui Medicine Docetaxel Product Offerings
Table 21. Hengrui Medicine Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 22. Sanofi Corporate Summary
Table 23. Sanofi Docetaxel Product Offerings
Table 24. Sanofi Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 25. Qilu Pharma Corporate Summary
Table 26. Qilu Pharma Docetaxel Product Offerings
Table 27. Qilu Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 28. Shenzhen Main Luck Pharma Corporate Summary
Table 29. Shenzhen Main Luck Pharma Docetaxel Product Offerings
Table 30. Shenzhen Main Luck Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 31. Jiangsu Aosaikang Pharma Corporate Summary
Table 32. Jiangsu Aosaikang Pharma Docetaxel Product Offerings
Table 33. Jiangsu Aosaikang Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 34. Docetaxel Production Capacity (K Units) of Local Manufacturers in Japan, 2015-2020
Table 35. Docetaxel Production (K Units) of Local Manufacturers in Japan, 2015-2020
Table 36. Japan Docetaxel Production Market Share of Local Manufacturers, 2015-2020
Table 37. Docetaxel Production Value (US$, Mn) of Local Manufacturers in Japan, 2015-2020
Table 38. Japan Docetaxel Production Value Market Share of Local Manufacturers, 2015-2020
Table 39. The Percentage of Docetaxel Production Sold in Japan and Sold Other Than Japan by Manufacturers
Table 40. The Percentage of Docetaxel Production Sold in Japan and Sold Other Than Japan by Manufacturers
Table 41. Dangeguojia Docetaxel Sales (Consumption), Production, Export and Import, 2015-2020
Table 42. Raw Materials and Suppliers
Table 43. Docetaxel Downstream Clients in Japan
Table 44. Docetaxel Distributors and Sales Agents in Japan
Table 1. Key Players of Docetaxel in Japan
Table 2. Top Players in Japan, Ranking by Revenue (2019)
Table 3. Japan Docetaxel Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Japan Docetaxel Revenue Share by Companies, 2015-2020
Table 5. Japan Docetaxel Sales by Companies, (K Units), 2015-2020
Table 6. Japan Docetaxel Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Docetaxel Price (2015-2020) (USD/Unit)
Table 8. Japan Manufacturers Docetaxel Product Type
Table 9. List of Japan Tier 1 Docetaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Japan Tier 2 and Tier 3 Docetaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Docetaxel Revenue in Japan (US$, Mn), 2015-2020
Table 12. By Type - Docetaxel Revenue in Japan (US$, Mn), 2021-2026
Table 13. By Type - Docetaxel Sales in Japan (K Units), 2015-2020
Table 14. By Type - Docetaxel Sales in Japan (K Units), 2021-2026
Table 15. By Application - Docetaxel Revenue in Japan, (US$, Mn), 2015-2020
Table 16. By Application - Docetaxel Revenue in Japan, (US$, Mn), 2021-2026
Table 17. By Application - Docetaxel Sales in Japan, (K Units), 2015-2020
Table 18. By Application - Docetaxel Sales in Japan, (K Units), 2021-2026
Table 19. Hengrui Medicine Corporate Summary
Table 20. Hengrui Medicine Docetaxel Product Offerings
Table 21. Hengrui Medicine Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 22. Sanofi Corporate Summary
Table 23. Sanofi Docetaxel Product Offerings
Table 24. Sanofi Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 25. Qilu Pharma Corporate Summary
Table 26. Qilu Pharma Docetaxel Product Offerings
Table 27. Qilu Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 28. Shenzhen Main Luck Pharma Corporate Summary
Table 29. Shenzhen Main Luck Pharma Docetaxel Product Offerings
Table 30. Shenzhen Main Luck Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 31. Jiangsu Aosaikang Pharma Corporate Summary
Table 32. Jiangsu Aosaikang Pharma Docetaxel Product Offerings
Table 33. Jiangsu Aosaikang Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 34. Docetaxel Production Capacity (K Units) of Local Manufacturers in Japan, 2015-2020
Table 35. Docetaxel Production (K Units) of Local Manufacturers in Japan, 2015-2020
Table 36. Japan Docetaxel Production Market Share of Local Manufacturers, 2015-2020
Table 37. Docetaxel Production Value (US$, Mn) of Local Manufacturers in Japan, 2015-2020
Table 38. Japan Docetaxel Production Value Market Share of Local Manufacturers, 2015-2020
Table 39. The Percentage of Docetaxel Production Sold in Japan and Sold Other Than Japan by Manufacturers
Table 40. The Percentage of Docetaxel Production Sold in Japan and Sold Other Than Japan by Manufacturers
Table 41. Dangeguojia Docetaxel Sales (Consumption), Production, Export and Import, 2015-2020
Table 42. Raw Materials and Suppliers
Table 43. Docetaxel Downstream Clients in Japan
Table 44. Docetaxel Distributors and Sales Agents in Japan
LIST OF FIGURES
Figure 1. Docetaxel Segment by Type
Figure 2. Docetaxel Segment by Application
Figure 3. Dangeguojia Docetaxel Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Docetaxel Market Size in Japan, (US$, Mn) & (K Units): 2020 VS 2026
Figure 6. Japan Docetaxel Revenue, 2015-2026 (US$, Mn)
Figure 7. Docetaxel Sales in Japan: 2015-2026 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Docetaxel Revenue in 2019
Figure 9. By Type - Japan Docetaxel Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Japan Docetaxel Market Share, 2015-2020
Figure 11. By Type - Japan Docetaxel Market Share, 2020-2026
Figure 12. By Type - Japan Docetaxel Price (USD/Unit), 2015-2026
Figure 13. By Application - Docetaxel Revenue in Japan (US$, Mn), 2020 & 2026
Figure 14. By Application - Japan Docetaxel Market Share, 2015-2020
Figure 15. By Application - Japan Docetaxel Market Share, 2020-2026
Figure 16. By Application -Japan Docetaxel Price (USD/Unit), 2015-2026
Figure 17. Japan Docetaxel Production Capacity (K Units), 2015-2026
Figure 18. Japan Docetaxel Actual Output (K Units), 2015-2026
Figure 19. Japan Docetaxel Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Japan Docetaxel Export Destination, 2019
Figure 21. The Source of Imports of Japan Docetaxel, 2019
Figure 22. PEST Analysis for Japan Docetaxel Market in 2020
Figure 23. Docetaxel Market Opportunities & Trends in Japan
Figure 24. Docetaxel Market Drivers in Japan
Figure 25. Docetaxel Market Restraints in Japan
Figure 26. Docetaxel Industry Value Chain
Figure 1. Docetaxel Segment by Type
Figure 2. Docetaxel Segment by Application
Figure 3. Dangeguojia Docetaxel Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Docetaxel Market Size in Japan, (US$, Mn) & (K Units): 2020 VS 2026
Figure 6. Japan Docetaxel Revenue, 2015-2026 (US$, Mn)
Figure 7. Docetaxel Sales in Japan: 2015-2026 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Docetaxel Revenue in 2019
Figure 9. By Type - Japan Docetaxel Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Japan Docetaxel Market Share, 2015-2020
Figure 11. By Type - Japan Docetaxel Market Share, 2020-2026
Figure 12. By Type - Japan Docetaxel Price (USD/Unit), 2015-2026
Figure 13. By Application - Docetaxel Revenue in Japan (US$, Mn), 2020 & 2026
Figure 14. By Application - Japan Docetaxel Market Share, 2015-2020
Figure 15. By Application - Japan Docetaxel Market Share, 2020-2026
Figure 16. By Application -Japan Docetaxel Price (USD/Unit), 2015-2026
Figure 17. Japan Docetaxel Production Capacity (K Units), 2015-2026
Figure 18. Japan Docetaxel Actual Output (K Units), 2015-2026
Figure 19. Japan Docetaxel Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Japan Docetaxel Export Destination, 2019
Figure 21. The Source of Imports of Japan Docetaxel, 2019
Figure 22. PEST Analysis for Japan Docetaxel Market in 2020
Figure 23. Docetaxel Market Opportunities & Trends in Japan
Figure 24. Docetaxel Market Drivers in Japan
Figure 25. Docetaxel Market Restraints in Japan
Figure 26. Docetaxel Industry Value Chain
